BlackRock, Inc. 13D and 13G filings for Haemonetics Corporation:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-01-23 4:13 pm Purchase |
2023-12-31 | 13G | Haemonetics Corporation HAE |
BlackRock Inc. BLK |
6,056,881 11.900% |
158,261 (+2.68%) |
Filing |
| 2023-01-26 08:52 am Unchanged |
2022-12-31 | 13G | Haemonetics Corporation HAE |
BlackRock Inc. BLK |
5,898,620 11.700% |
0 (Unchanged) |
Filing |
| 2023-01-20 3:00 pm Sale |
2022-12-31 | 13G | Haemonetics Corporation HAE |
BlackRock Inc. BLK |
5,898,620 11.700% |
-793,726 (-11.86%) |
Filing |
| 2022-01-26 8:18 pm Unchanged |
2021-12-31 | 13G | Haemonetics Corporation HAE |
BlackRock Inc. BLK |
6,692,346 13.100% |
0 (Unchanged) |
Filing |
| 2022-01-25 11:15 am Purchase |
2021-12-31 | 13G | Haemonetics Corporation HAE |
BlackRock Inc. BLK |
6,692,346 13.100% |
713,043 (+11.93%) |
Filing |
| 2021-07-09 6:05 pm Purchase |
2021-06-30 | 13G | Haemonetics Corporation HAE |
BlackRock Inc. BLK |
5,979,303 11.700% |
1,278,712 (+27.20%) |
Filing |
| 2021-01-29 09:56 am Sale |
2020-12-31 | 13G | Haemonetics Corporation HAE |
BlackRock Inc. BLK |
4,700,591 9.300% |
-1,210,269 (-20.48%) |
Filing |